Since all omega values but one are positive in both DUR experimental hospitals, it describes a general tendency for improvement whereas this tendency is toward reduced appropriateness in the control hospital in which omega values are all negative.
Compared with preoperative status for the whole group, quality of life also showed an improvement, whereas disability did not improve significantly.
Increased viability of the cultivated yeast thus accounted for some of the improvement, whereas the remainder was attributed to improved fermentation performance, as indicated by the increased fermentative capacity.
Omeprazole administration also statistically significantly improved sleep quality (PSQI 15.1%, ESS 15.9%, diary record 14.3% improvement), whereas administration of the placebo had no significant therapeutic effect (3.4%, 7.7%, and 0% respectively) (Table 4a and Figure 2).
The study group trended toward improvement, whereas the control group performance declined substantially between pre- and posttests.
For the palliative treatment of dysphagia, esophageal stent placement provides immediate improvement, whereas brachytherapy offers better long-term relief.
Two 100 nucleotide ssRNAs with slight sequence variation both dramatically increased the gene editing efficiency of Cpf1, resulting in a twofold improvement, whereas the 9 nucleotide ssRNA induced only a 10% enhancement in gene editing efficiency (Fig. 3e).
The FP allows scaling by about 10 times compared to the RR with a small performance improvement, whereas the MNP enables 2 orders scaling past the highest FP FOM.
Postoperative evaluation showed 27 patients (73%) to have been completely cured, four (9.25%) to have a considerable improvement, whereas six patients (16.2%) were classified as failures.
EC process was not effective in case of biodegradability improvement whereas EC along with UV/oxidant could significantly increase biodegradability (BOD5/COD ratio).
